氨诱导的细胞死亡:增强癌症免疫疗法的新前沿
Urushi Rehman1, Garima Gupta2,3, Amirhossein Sahebkar4,5
1Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard, New Delhi, India.
Immunology
|March 4, 2025
概括
在癌症免疫治疗中,有毒氨的积累导致T细胞死亡. 针对这种氨诱导细胞死亡 (AICD) 可能通过提高T细胞存活率和促进抗瘤反应来改善治疗.
科学领域:
- 免疫学 免疫学 免疫学
- 代谢途径 代谢途径
- 癌症生物学 癌症生物学
背景情况:
- 癌症免疫疗法的有效性受到T细胞耗尽和抑制瘤微环境的限制.
- 一种新的机制,氨诱导细胞死亡 (AICD),有助于 CD8+ T 细胞功能障碍.
- AICD是代谢重编程的结果,特别是增加了谷氨胺代谢,导致有毒氨积累.
研究的目的:
- 阐明氨诱导细胞死亡 (AICD) 在癌症免疫疗法期间T细胞衰减中的作用.
- 探索T细胞死亡的代谢基础及其对免疫调节的影响.
- 确定针对AICD的新型治疗策略,以改善癌症治疗结果.
主要方法:
- 研究了氨积累对T细胞存活和功能的影响.
- 分析了氨引起的细胞损伤,包括溶酶体和线粒体功能障碍.
- 在免疫激活期间检查了代谢重编程,专注于谷氨酸代谢.
主要成果:
- 在免疫激活期间增加的谷氨胺代谢会导致有毒氨水平.
- 氨会损害溶解体和线粒体,破坏细胞平衡,并诱导亡.
- AICD显著影响 CD8+ T 细胞存活率和抗瘤功能.
结论:
- 氨诱导细胞死亡 (AICD) 是癌症免疫治疗中的一个关键的代谢瓶.
- 通过抑制氨运输,增强自或吸收氨来准AICD提供了治疗潜力.
- 调节氨代谢可以增强现有的免疫疗法,如检查点抑制剂和CAR T细胞疗法,特别是在"冷"瘤中.
相关概念视频
Tumor Immunotherapy
461
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
461
Cancer Vaccines
324
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
324
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cytotoxic T Cells-mediated Immune Response
825
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
825
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K


